Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
12%
Alzheimer's Disease
12%
Anti-inflammatory Effect
11%
Antipsychotics
44%
Auditory Hallucinations
30%
Brain Disorders
20%
Cardiac Surgery
10%
Childhood Trauma
22%
Cognitive Domains
10%
Cognitive Functioning
15%
Cognitive-affective Processes
10%
Daily Functioning
11%
Delusions
11%
Depressive Symptoms
21%
Divergent Effects
10%
Estrogen
24%
First-episode Psychosis
61%
Hallucinations
27%
Healthy Controls
12%
Hedge's g
27%
Language Perception
10%
Long-term Evaluation
11%
Meta-analysis
64%
Negative Symptoms
24%
Neuroticism
12%
Non-invasive Brain Stimulation
10%
Oxytocin Augmentation
10%
Parkinson's Disease
14%
Patients with Schizophrenia
23%
Personality Traits
11%
Placebo
11%
Positive Symptoms
23%
Prolactin
10%
Psychiatrists
23%
Psychotic Experiences
22%
Psychotic Symptoms
15%
Randomized Controlled Trial
13%
Randomized Placebo-controlled Trial
12%
Remission
17%
Schizophrenia
27%
Schizophrenia Spectrum Disorders
37%
Semantic Space Models
10%
Simvastatin
11%
Symptom Severity
29%
Systematic Meta-analysis
31%
Targeted Treatment
13%
Transdiagnostic
11%
Traumatic Brain Injury
11%
White Matter Integrity
10%
Working Memory
15%
Neuroscience
Acetylcholinesterase Inhibitor
12%
Alzheimer's Disease
12%
Anti-Inflammatory
12%
Anti-Inflammatory Agent
11%
Antipsychotic
23%
Antipsychotic
10%
Aspirin
6%
Auditory Hallucination
30%
Bipolar Disorder
10%
Clozapine
10%
Cognitive Disorders
11%
Delusion
8%
Dementia Praecox
87%
Depression
30%
Drug Therapy
10%
Electroconvulsive Therapy
10%
Enhancer Region
10%
Fractional Anisotropy
16%
Gray Matter
10%
Hallucination
32%
Levosulpiride
10%
Magnetic Resonance Imaging
10%
Meta-Analysis
100%
Negative Syndrome
48%
Neuro-Inflammation
10%
Neurotransmitter
8%
Neurotrauma
11%
Non-Invasive Brain Stimulation
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Oxytocin
10%
Parkinson's Disease
14%
Pediatric Trauma
32%
Placebo
36%
Positive Syndrome
22%
Progesterone
10%
Prolactin
10%
Psychiatry
11%
Psychosis
33%
Raloxifene
12%
Randomized Controlled Trial
17%
Schizophrenia Spectrum Disorder
58%
Selective Estrogen Receptor Modulator
8%
Sex Hormone
20%
Simvastatin
11%
Sulpiride
10%
Transcranial Direct Current Stimulation
10%
Transcranial Magnetic Stimulation
10%
Traumatic Brain Injury
11%
Treatment of Schizophrenia
6%
Working Memory
14%
Medicine and Dentistry
6 Quinoxalinecarboxylic Acid Piperidide
6%
Acetylcholinesterase Inhibitor
10%
Alzheimer's Disease
10%
Citalopram
6%
Clozapine
10%
Delusion
7%
Depression
10%
Diethylstilbestrol
5%
Diffusion Tensor Imaging
5%
Disease
9%
Drug Dose Reduction
10%
Drug Therapy
32%
Effect Size
15%
Estrogen Therapy
5%
Hallucination
17%
Heart Surgery
10%
Injury
7%
Lamotrigine
6%
Levosulpiride
10%
Meta-Analysis
28%
Negative Syndrome
36%
Nonsteroid Antiinflammatory Agent
10%
Observational Study
10%
Oxytocin
10%
Parkinson's Disease
10%
Pediatric Trauma
10%
Placebo
26%
Positive Syndrome
14%
Psychiatrist
12%
Psychosis
21%
Randomized Controlled Trial
17%
Schizophrenia Spectrum Disorder
19%
Selective Estrogen Receptor Modulator
6%
Sex Hormone
10%
Side Effect
7%
Simvastatin
11%
Speech Analysis
5%
Speech Production
5%
Symptom
56%
Symptomatology
10%
Targeted Therapy
11%
Topiramate
6%
